{"id":"NCT00296036","sponsor":"Alliance for Clinical Trials in Oncology","briefTitle":"Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer","officialTitle":"A Phase III Randomized, Placebo-controlled, Double-blind Trial to Determine the Effectiveness of a Urea/Lactic Acid-Based Topical Keratolytic Agent and Vitamin B-6 for Prevention of Capecitabine-Induced Hand and Foot Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06","primaryCompletion":"2009-07","completion":null,"firstPosted":"2006-02-24","resultsPosted":"2017-03-16","lastUpdate":"2017-03-16"},"enrollment":137,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Breast Cancer","Drug/Agent Toxicity by Tissue/Organ","Unspecified Adult Solid Tumor, Protocol Specific"],"interventions":[{"type":"DIETARY_SUPPLEMENT","name":"pyridoxine hydrochloride","otherNames":[]},{"type":"DRUG","name":"urea/lactic acid-based topical cream","otherNames":[]},{"type":"OTHER","name":"placebo","otherNames":[]}],"arms":[{"label":"Arm I (closed to accrual as of 10/24/2007)","type":"EXPERIMENTAL"},{"label":"Arm II (closed to accrual as of 10/24/2007)","type":"EXPERIMENTAL"},{"label":"Arm III (closed to accrual as of 10/24/2007)","type":"EXPERIMENTAL"},{"label":"Arm IV (closed to accrual as of 10/24/2007)","type":"PLACEBO_COMPARATOR"},{"label":"Arm V","type":"EXPERIMENTAL"},{"label":"Arm VI","type":"PLACEBO_COMPARATOR"}],"summary":"RATIONALE: Pyridoxine (vitamin B6) and topical urea/lactic acid-based cream may prevent or lessen hand-foot syndrome caused by chemotherapy. It is not yet known whether giving pyridoxine with or without topical urea/lactic acid-based cream is more effective than topical urea/lactic acid-based cream alone or a placebo in preventing hand-foot syndrome.\n\nPURPOSE: This randomized phase III trial is studying pyridoxine and topical urea/lactic acid-based cream to see how well they work compared with giving pyridoxine together with a placebo, giving topical urea/lactic acid-based cream together with a placebo, or giving two placebos in preventing hand-foot syndrome in patients who are receiving capecitabine for breast cancer or other cancer.","primaryOutcome":{"measure":"To Determine Whether the Prophylactic Use of a Topical Urea/Lactic Acid Cream Can Decrease the Incidence/Severity of Capecitabine-caused Palmar-plantar Erythrodysesthesia","timeFrame":"First 3 weeks of treatment","effectByArm":[{"arm":"Urea/Lactic Acid Cream","deltaMin":13.6,"sd":null},{"arm":"Placebo Cream","deltaMin":10.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.768"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":231,"countries":["United States"]},"refs":{"pmids":["21060036"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":67},"commonTop":["Hand-and-foot syndrome","Diarrhea","Dehydration","Fatigue","Nausea"]}}